Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00767676 · ClinicalTrials.gov registry record · Phase 1
Contact Sensitization Potential of 828 Ointment
A Phase 1 study, sponsored by Healthpoint.
- Completed
- Registry status
- Phase 1
- Development phase
- 259
- Enrollment target
NCT00767676: Completed Phase 1 study, sponsored by Healthpoint.
NCT00767676 is a Phase 1 study that has completed, run by Healthpoint. The registered enrollment target is 259 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (332% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00767676, a Phase 1 study, has completed, sponsored by Healthpoint.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 259 participants
- Enrollment target
Study Summary
Contact sensitization by patch applications.
Primary Outcome
To qualify for the claim of a reduced sensitization potential, all subjects completing the study could exhibit a value of no more than 1.5 on the Jordan-King Scale \[scale is 0 (no visible reaction) to 5 (severe erythema)\] No statistical analyses were performed.
Interventions
- DEVICE HP828-101
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 259 participants |
| Start Date | 2008-10 |
| Est. Completion | 2008-11 |
| Phase | Phase 1 |
What the finished NCT00767676 record still lists
NCT00767676 is an interventional study that assigns participants to a tested intervention. The registered 259 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (332% higher).
The record links to 0 conditions, and to 1 intervention - of which HP828-101 is the first listed.
NCT00767676 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00767676 about?
NCT00767676 is a clinical study titled "Contact Sensitization Potential of 828 Ointment". Contact sensitization by patch applications.
What is the current status of trial NCT00767676?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 259 participants. The study started on 2008-10. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00767676?
The interventions under investigation include: HP828-101 (DEVICE).
Who is sponsoring clinical trial NCT00767676?
This trial is sponsored by Healthpoint, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00767676's enrollment target sits among peer trials
259 167th of 2000 higher than 1,834 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02361320 · 259 participants · NA
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer
- NCT06797258 · 259 participants · NA
FlexHD® Pliable Investigation in Implant-Based Breast Reconstruction
- NCT06990425 · 259 participants · NA
CLOSM Trial: Groin Closure Using Layered Option for Suture Material
- NCT07399977 · 259 participants · NA
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia